Lapatinib Completed Phase 2 Trials for Brain Cancer / Pediatric Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00883688Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma